Picture of Biophytis SA logo

ALBPS — Biophytis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Biophytis End-June Cash And Cash Equivalents At EUR 19.7 mln

Jan 31 (Reuters) - Biophytis SA  ALBPS.PA :
    * BIOPHYTIS PUBLISHES ITS FINANCIAL RESULTS FOR THE FIRST
HALF OF
2022
    * CASH AND CASH EQUIVALENTS: EUR 19.7M AS OF JUNE 30, 2022
    * NET LOSS DOWN 8% AT EUR 12.4M FOR FIRST HALF OF 2022
    * RESEARCH AND DEVELOPMENT EXPENSES. NET RESEARCH AND
DEVELOPMENT
EXPENSES WERE EUR 6.9 MILLION FOR FIRST HALF OF 2022, A DECREASE
OF EUR 0.7 MILLION, COMPARED TO EUR 7.6 MILLION IN FIRST HALF OF
2021

Source text for Eikon:  ID:nEQWTC4Ma 
Further company coverage:  ALBPS.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Biophytis SA

See all news